Global Companion Diagnostics Partnering Deal Trends, Players, Financials and Forecasts Report 2018
Apr 18, 2018 10:29 am UTC| Business
Dublin, April 18, 2018 -- The "Global Companion Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts" report has been added to ResearchAndMarkets.com's offering. The...
Global Biomarker Partnering Terms and Agreements Directory 2010-2018
Apr 18, 2018 10:25 am UTC| Business
Dublin, April 18, 2018 -- The "Global Biomarker Partnering Terms and Agreements 2010-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. The...
Apr 18, 2018 10:25 am UTC| Business
Dublin, April 18, 2018 -- The "Financing Water to 2030" report has been added to ResearchAndMarkets.com's offering. Financing Water to 2030 and its accompanying databases provide you with a detailed...
2018 MEDICARE TAIWAN Presents Three New Themes Synchronizing the Latest Medical Trends
Apr 18, 2018 10:17 am UTC| Business
Taipei, Taiwan, April 18, 2018 -- The 2018 MEDICARE TAIWAN (Taiwan International Medical Healthcare Exhibition) and SenCARE (Taiwan International Senior Lifestyle and Health Care Show), organized by Taiwan External...
GDS Acquires Third Data Center in Guangzhou
Apr 18, 2018 10:00 am UTC| Business
SHANGHAI, China, April 18, 2018 -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ:GDS), a leading developer and operator of high-performance data centers in China, today announced that it has...
Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure
Apr 18, 2018 10:00 am UTC| Business
NEW YORK and MELBOURNE, Australia, April 18, 2018 -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today provided an update on the Phase 3 and Phase 2b clinical trials of the Company's proprietary allogeneic mesenchymal...
PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR CANCER COMBINATION THERAPY
Apr 18, 2018 10:00 am UTC| Business
FOR IMMEDIATE RELEASE KNOXVILLE, TN, April 18, 2018 -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) (“Provectus” or the “Company”), a clinical-stage biotechnology company developing PV-10...